Skip to main content

Mithril II GP LP

SEC CIK
0001878232
Latest filing
Nov 12, 2025

The latest 13F from Mithril II GP LP covers Q3 2025 (filed Nov 12, 2025): 3 long positions worth $64.5M. The top 10 holdings make up 100.0% of the portfolio, and the largest is Figure Technology Solutions, Inc. (FIGR) at 48.6%. Livermore has 4 filings on Form 13F from this institution, going back to Q4 2024.

What changed in Q3 2025

Share counts compared with Q2 2025: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
1
Est. +$31.4M
Added
0
Reduced
0
Sold out
0

Top 5 holdings

Share of this quarter's portfolio value

  1. FIGRFigure Technology Solutions, Inc.
    48.6%$31.4MHistory
  2. BKSYBlackSky Technology Inc.
    32.2%$20.8MHistory
  3. IVVDInvivyd, Inc.
    19.2%$12.4MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. FIGRFigure Technology Solutions, Inc.
    +$31.4MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. FIGRFigure Technology Solutions, Inc.
    +48.63 pp0.0% → 48.6%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

None this quarter.

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

None this quarter.

Metrics

13F metrics for Q3 2025, computed only from the numbers in the filings. Definitions below.

Portfolio value
$64.5M
+$35.2M (+120.5%) vs. prior quarter
Positions
3
+1 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
0.0%
Q3 2025, one quarter
Average holding period
2.5 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2024), so positions held before then are understated.

13F filings by quarter

4 quarters, going back to Q4 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $64.5M (Q3 2025)

Q4 2024: $16.1MQ1 2025: $14.8MQ2 2025: $29.2MQ3 2025: $64.5M
Q4 2024Q3 2025
13F filings of Mithril II GP LP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q3 2025Nov 12, 20253$64.5MFIGRBKSYIVVDvs. Q2 2025SEC
Q2 2025Aug 12, 20252$29.2MBKSYIVVDvs. Q1 2025SEC
Q1 2025May 9, 20252$14.8MBKSYIVVDvs. Q4 2024SEC
Q4 2024Feb 14, 20252$16.1MBKSYIVVD–SEC

13D and 13G filings

Companies where Mithril II GP LP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Mithril II GP LP does not currently report owning 5% or more of any company.

Latest filings

4 filings on file made by Mithril II GP LP or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Mithril II GP LP
CompanyFiled (ET)FilerFormStakeChangeEvent dateFiling
GUTSFractyl Health, Inc.Feb 12, 20264:18 PM ETMithril LPand 6 others13G/A4.70%6.46M shares–Below 5%Dec 31, 2025SEC
IVVDInvivyd, Inc.Nov 12, 20255:02 PM ETMithril II LPand 4 others13D/A4.80%11.2M shares–Below 5%Aug 22, 2025SEC
BKSYBlackSky Technology Inc.Aug 11, 20255:27 PM ETMithril LPand 6 others13D/A6.60%2.33M shares–Aug 7, 2025SEC
OKLOOklo Inc.Feb 14, 20254:50 PM ETMithril II LPand 4 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC